Top Page
China Life Insurance Co
(2628)
China Life Insurance Co (2628) vs. iShares MSCI Hong Kong ETF (EWH)
China Life Insurance Co Business Overview & Revenue Model
China Life Insurance Co Earnings Call Summary
China Life Insurance Co Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 516.98B | 512.20B | 396.47B | 822.30B | 848.11B | 816.68B |
| Gross Profit | 515.20B | 510.40B | 394.74B | 66.12B | 85.99B | 56.08B |
| EBITDA | 221.69B | 120.24B | 57.00B | 33.84B | 60.88B | 62.94B |
| Net Income | 109.59B | 106.94B | 51.18B | 32.08B | 50.77B | 50.26B |
Balance Sheet | ||||||
| Total Assets | 7.29T | 6.77T | 5.89T | 5.25T | 4.89T | 4.25T |
| Cash, Cash Equivalents and Short-Term Investments | 120.93B | 86.52B | 2.41T | 1.87T | 1.49T | 1.27T |
| Total Debt | 36.97B | 49.27B | 48.97B | 49.34B | 55.86B | 57.21B |
| Total Liabilities | 6.76T | 6.25T | 5.42T | 4.81T | 4.40T | 3.80T |
| Stockholders Equity | 523.62B | 509.68B | 460.11B | 436.17B | 478.58B | 450.05B |
Cash Flow | ||||||
| Free Cash Flow | 329.56B | 374.82B | 384.06B | 348.89B | 280.97B | 296.56B |
| Operating Cash Flow | 300.44B | 378.80B | 388.23B | 351.97B | 286.45B | 304.02B |
| Investing Cash Flow | -449.35B | -354.62B | -428.10B | -164.96B | -393.73B | -292.80B |
| Financing Cash Flow | 81.58B | -86.76B | 60.27B | -120.09B | 111.14B | -7.76B |
China Life Insurance Co Technical Analysis
China Life Insurance Co Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | HK$220.28B | 5.25 | 34.37% | 5.36% | 49.90% | 203.77% | |
83 Outperform | HK$1.28T | 6.87 | 28.10% | 3.37% | 17.69% | 126.41% | |
78 Outperform | HK$418.91B | 6.24 | 17.99% | 3.04% | 9.40% | 79.93% | |
76 Outperform | $409.24B | 6.04 | 18.41% | 3.31% | 15.08% | 23.13% | |
72 Outperform | HK$1.29T | 7.78 | ― | 4.28% | 10.20% | 19.74% | |
71 Outperform | HK$68.50B | 8.38 | 10.74% | 1.84% | 23.64% | 36.32% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
China Life Insurance Co Corporate Events
China Life Insurance Company Limited has announced the convening of its Second Extraordinary General Meeting in December 2025, where shareholders will consider resolutions related to investment and management agreements with its subsidiaries. The meeting’s outcomes could impact the company’s strategic investment initiatives and operational collaborations, potentially influencing its market positioning and stakeholder relationships.
China Life Insurance Co has announced the renewal of its continuing connected transactions with AMP, a subsidiary of its associate company, under a new Framework Agreement set to be finalized by December 31, 2025. This agreement will allow CLI to continue its daily transactions with AMP, including the subscription and redemption of fund products and private asset management. The transactions are subject to specific reporting and approval requirements under the Hong Kong and SSE Listing Rules, given the significant cumulative transaction amount between the involved parties.
China Life Insurance Company Limited has announced plans to enter a new agreement with its subsidiary, CLI, for the management of insurance fund investments. This agreement, effective from January 2026, will see CLI continue to manage assets on behalf of China Life, with the transactions categorized as continuing connected transactions under Hong Kong’s listing rules. The agreement requires independent shareholder approval due to the significant percentage ratios involved, and an extraordinary general meeting will be convened for this purpose. The new agreement aims to ensure compliance with regulatory requirements and enhance investment management services, potentially impacting the company’s operational efficiency and stakeholder interests.
China Life Insurance Company Limited has reported significant financial growth in its 2025 third quarter report. The company’s total assets increased by 9.6% to RMB 7,417,981 million, and equity attributable to equity holders rose by 22.8%. Operating income saw a substantial rise of 54.8% for the quarter, with a net profit before income tax increasing by 114.3%. These results indicate a strong financial performance, reflecting positively on the company’s market position and potentially benefiting stakeholders.
China Life Insurance Company Limited has released its solvency quarterly report for the third quarter of 2025, prepared under the guidelines of the National Financial Regulatory Administration. This report reflects the company’s adherence to regulatory standards and provides insights into its financial health, which is crucial for maintaining stakeholder confidence and ensuring continued operations within the competitive insurance market in China.
China Life Insurance Company Limited has announced a connected transaction involving a significant capital contribution to an Equity Investment Plan established by China Life Industries. The company plans to invest RMB2,000,000,000, while China Life Industries will contribute RMB10,000,000. This investment is structured under an entrustment contract with CLI, and aims to subscribe to a limited partnership interest in the Partnership. The transaction is categorized as a connected transaction under the Listing Rules, subject to reporting and announcement requirements, but exempt from independent shareholders’ approval.
China Life Insurance Company Limited has announced the renewal of its framework agreement with AMP, allowing for continued daily transactions such as the subscription and redemption of fund products and private asset management. These transactions are classified as continuing connected transactions under Hong Kong’s Listing Rules, with specific exemptions from independent shareholder approval due to the applicable percentage ratios. This renewal is expected to maintain operational continuity and compliance with regulatory requirements, impacting the company’s financial dealings and strategic partnerships.
China Life Insurance Company Limited announced that it will release its 2025 third quarter results on October 30, 2025, and will hold a results briefing on the same day to provide investors with a deeper understanding of its financial performance and business operations. The briefing will be conducted via webcast and text interaction, allowing investors to engage with the company’s senior management and ask questions, thereby enhancing transparency and communication with stakeholders.
China Life Insurance Company Limited has announced an estimated significant increase in net profit for the first three quarters of 2025, with expectations of a 50% to 70% rise compared to the same period in 2024. This growth is attributed to strategic asset-liability management, investment in new productive forces, and a recovering stock market, enhancing the company’s investment returns and long-term stability.
China Life Insurance Company Limited has announced a board meeting scheduled for October 30, 2025, to consider and approve its unaudited financial results for the first three quarters of 2025. This meeting is significant as it will provide insights into the company’s financial health and performance, potentially impacting its market positioning and stakeholder confidence.
China Life Insurance Company Limited has announced an updated interim dividend for the first half of 2025, declaring RMB 0.238 per share, with the payment to be made in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.093446. The announcement outlines the withholding tax rates applicable to different categories of shareholders, impacting both enterprise and individual non-resident shareholders, as well as Mainland investors using the Hong Kong Stock Connect Program.
China Life Insurance Company Limited announced that all resolutions were passed at its first extraordinary general meeting of 2025, including the distribution of an interim dividend. The meeting saw a significant turnout, with 77.5% of the total voting shares represented, reflecting strong shareholder engagement and compliance with relevant Chinese laws and regulations.